Michael W. Straza, MD/PhD

Radiation Oncologist @MCWRadOnc specializing in brain, liver and prostate cancer. Proud father, NPS enthusiast, and Chicago transplant All tweets are my own.

[Drew Moghanaki @DrewMoghanaki]

It’s time to revisit the value of nephrectomy for RCC and when it might actually be a better treatment.

[Daniel E Spratt @DrSpratticus]

Hence why people don’t trust science or MDs anymore. We have a doctor you posted likely paid saying they violated national guidelines for what payers deem experimental, we have biomedical news agencies funded by industry saying these devices are amazing for things they are not approved for, we have major medical meetings promoting these devices, we even have @nytimes articles saying how great these devices are.

Yet reality is there is not a single well done multi center randomized trial with reasonable endpoints and good followup showing it is better than AS or RT.

To be clear, none of this is targeting the Vanquish system. It is the whole field of ablative devices being used for cancer without being approved for cancer.

[Michael W. Straza, MD/PhD @WStraza]

@marklewismd Friday me does this to Monday me every week

[Michael W. Straza, MD/PhD @WStraza]

@joshuapalmermd @DrAMansouri Agree, no shortage of need. Radiographic localization of a sensitive emitter would inform a lot of the debate around margins, both upfront and in recurrence.

[David Sher @DavidSherMD]

@SprakerMDPhD @NiuSanford As if on cue:

https://t.co/eYFyYyFXhU

@RonaldChenMD

[Michael W. Straza, MD/PhD @WStraza]

@joshuapalmermd @ASTRO_org @ESTRO_RT @NeuroOnc @HaleyPerlow @OhioStateRadOnc Also impressive work, character limit forces one to trim the niceties.

[Michael W. Straza, MD/PhD @WStraza]

@joshuapalmermd @ASTRO_org @ESTRO_RT @NeuroOnc @HaleyPerlow @OhioStateRadOnc What portion of these were treated outpatient versus inpatient? Logistics of SRS and OR time and all preradiosurgical/surgical planning has been biggest barrier to making this routine. I see the median time from SRS to surgery was 1 day, but how long from diagnosis to SRS?

[Milwaukee Brewers @Brewers]

COMEBACK COMPLETE!!!!!!!!!!!!!!!!!!!!!!!!!!!

[Michael W. Straza, MD/PhD @WStraza]

@DrChowdharyMD @ProtonStorey @drmattmc Adaptive therapy probably should be the purview of full time clinicians rather than creating a new source of labor.

[Michael W. Straza, MD/PhD @WStraza]

@marklewismd Welcome to our fair city

[Michael W. Straza, MD/PhD @WStraza]

@marklewismd If this isn’t always 4:30 on a Friday

[Michael W. Straza, MD/PhD @WStraza]

@SeanFennessey The rare successful reverse jinx

[Journal of Neuro-Oncology @JNeurooncol]

Riegel et al. @BrittaBureauMD @MedicalCollege analyzed real-world outcomes for newly diagnosed GBM patients treated with or without TTFields and found that TTFields improved OS and PFS, with higher device usage linked to better outcomes. #JNO

Read more:https://t.co/iUf2E2o5bH

[Michael W. Straza, MD/PhD @WStraza]

2 years since we saw this man healthy in the playoffs. #letsgoBucks

[Milwaukee Bucks @Bucks]

RT if you love Giannis Antetokounmpo.

[Michael W. Straza, MD/PhD @WStraza]

@nathanmarzion 2 clutch blocks to boot

[Michael W. Straza, MD/PhD @WStraza]

@joshuapalmermd Up is down, right is left. It is hard to tell how many patients with poor prognosis were filtered out via eligibility and binning in cohort C, but given the modest study size, and no direct comparison to standard of care for brain mets I can’t say this should change anything

[Michael W. Straza, MD/PhD @WStraza]

@cwspeers @UMichRadOnc @RadOncUH @DrSpratticus @UABmedphys @UABradonc Congratulations and good luck!

[blange00 @blange00]

Now tell me who the real MVP is

[Malika Siker, MD @DrMalikaSiker]

Congratulations to Dr. @whallradonc on being named the next Chair for @MCWRadOnc! We are so fortunate to have him as our next leader. I look forward to working with him to advance @MedicalCollege and @MCWCancerCenter's impact in cancer care and beyond.